Search
Disruptions to U.S. local public health’s role in population-based substance use prevention and response during COVID-19
Background
COVID-19 dramatically limited the scale and scope of local health department (LHD) work, redirecting resources to the response. However, the need for essential public health services—including substance use prevention—was not...
HealthCare educational differences in pain management, adverse childhood experiences and their relationship to substance use disorder education
The Ohio Attorney General selected experts from a number of academic fields to the Scientific Committee on Opioid Prevention and Education (SCOPE) to help the State of Ohio in tackling the opioid crisis in the United States. The focus of...
Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017
One of the most serious public health concerns in recent decades has been the opioid epidemic in the United States (US). Over 9.9 million Americans aged 12 and up abused prescription pain drugs in 2018, and roughly 2 million Americans were...
High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder
In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member